Bajaj Finserv Healthcare Fund vs Mirae Asset Nifty 500 Healthcare ETF
Bajaj vs Mirae· Portfolio Overlap Analysis
53.9%High Overlap
24 common stocksRank #7312 / 20,000
Investor takeaway: At 53.9% overlap, a significant part of these portfolios is identical. Despite coming from different AMCs, the stock picks still converge heavily. Make sure both funds actually serve different jobs in your allocation.
Common Holdings (24)
| Stock | Wt% in Bajaj Finserv Healthcare | Wt% in Mirae Asset Nifty 500 Healthca | Overlap |
|---|---|---|---|
Sun Pharmaceutical Industries Limited Pharmaceuticals & Biotechnology | 8.40% | 10.02% | 8.40% |
Divi's Laboratories Limited Pharmaceuticals & Biotechnology | 9.21% | 6.80% | 6.80% |
Apollo Hospitals Enterprise Limited Healthcare Services | 6.80% | 6.72% | 6.72% |
Max Healthcare Institute Limited Healthcare Services | 4.40% | 6.78% | 4.40% |
Torrent Pharmaceuticals Limited Pharmaceuticals & Biotechnology | 5.46% | 3.78% | 3.78% |
Fortis Healthcare Limited Healthcare Services | 3.60% | 4.10% | 3.60% |
Aurobindo Pharma Limited Pharmaceuticals & Biotechnology | 5.93% | 2.85% | 2.85% |
Lupin Limited Pharmaceuticals & Biotechnology | 2.65% | 4.66% | 2.65% |
Glenmark Pharmaceuticals Limited Pharmaceuticals & Biotechnology | 1.88% | 2.69% | 1.88% |
IPCA Laboratories Limited Pharmaceuticals & Biotechnology | 2.45% | 1.77% | 1.77% |
Biocon Limited Pharmaceuticals & Biotechnology | 1.42% | 2.32% | 1.42% |
Krishna Institute Of Medical Sciences Limited Healthcare Services | 1.18% | 1.54% | 1.18% |
Abbott India Limited Pharmaceuticals & Biotechnology | 1.46% | 1.13% | 1.13% |
Cipla Limited Pharmaceuticals & Biotechnology | 1.02% | 6.33% | 1.02% |
Neuland Laboratories Limited Pharmaceuticals & Biotechnology | 3.40% | 0.92% | 0.92% |
Dr. Lal Path Labs Limited Healthcare Services | 1.57% | 0.91% | 0.91% |
GlaxoSmithKline Pharmaceuticals Limited Pharmaceuticals & Biotechnology | 1.94% | 0.89% | 0.89% |
Piramal Pharma Limited Pharmaceuticals & Biotechnology | 6.21% | 0.81% | 0.81% |
Eris Lifesciences Limited Pharmaceuticals & Biotechnology | 1.08% | 0.61% | 0.61% |
Jubilant Pharmova Limited Pharmaceuticals & Biotechnology | 0.96% | 0.58% | 0.58% |
AstraZeneca Pharma India Limited Pharmaceuticals & Biotechnology | 0.92% | 0.45% | 0.45% |
Vijaya Diagnostic Centre Limited Healthcare Services | 1.97% | 0.41% | 0.41% |
Emcure Pharmaceuticals Limited Pharmaceuticals & Biotechnology | 3.79% | 0.36% | 0.36% |
Alembic Pharmaceuticals Limited Pharmaceuticals & Biotechnology | 0.90% | 0.33% | 0.33% |
Unique to Bajaj Finserv Healthcare
- Rubicon Research Limited3.70%
Unique to Mirae Asset Nifty 500 Healthca
- Dr. Reddy's Laboratories Ltd.6.54%
- Laurus Labs Ltd.3.49%
Sector Overlap Breakdown
Pharmaceuticals & Biotechnology36.6% (18)
Healthcare Services17.2% (6)
More comparisons for Bajaj Finserv Healthcare
- vs LIC MF HEALTHCARE52.5% · 14 stocks
- vs ADITYA BIRLA SUN LIFE NIFTY HE50.7% · 14 stocks
- vs Axis NIFTY Healthcare ETF50.7% · 14 stocks
- vs ICICI Prudential Nifty Healthc50.7% · 14 stocks
- vs DSP Nifty Healthcare ETF50.6% · 14 stocks
More comparisons for Mirae Asset Nifty 500 Healthca
- vs Motilal Oswal BSE Healthcare E88.9% · 50 stocks
- vs ADITYA BIRLA SUN LIFE NIFTY HE78.3% · 20 stocks
- vs Axis NIFTY Healthcare ETF78.3% · 20 stocks
- vs DSP Nifty Healthcare ETF78.3% · 20 stocks
- vs ICICI Prudential Nifty Healthc78.3% · 20 stocks
Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.